Latest news

Filter News Articles

Conditions






Topics




















New research and tools for speech pathology

Communication is a fundamental human right. Associate Professor Anne Whitworth from Curtin University is developing a new NARNIA Communication App to help people with communication issues after stroke. This is one of the newly funded projects from our record-breaking $10 million research contribution in 2021.

Vale Dr Greg Brotherson

It is with sadness we advise that Dr Greg Brotherson passed away on Friday, 6 August 2021.

Dr Greg Brotherson.
“IT’S HUGE!” - MSWA Albany progress update, August 2021

Over her 25 years as a volunteer, employee and Client, Caroline Clarke-Smith has seen MSWA’s presence in Albany grow from a small support group to the development of a $7m facility for people living with neurological conditions.

MSWA Albany Services Centre and High Support Accommodation.
MS medication Aubagio (teriflunomide) delisted from Australian market

Aubagio (teriflunomide) a medication used to treat multiple sclerosis is being delisted in Australia by Sanfoli. Generic medications remain available.

MSWA Commitment to Research, 2021 Announcement

Today, MSWA is proud to announce that in this 2021/22 financial year, we are committing a record-breaking amount of $10 million to neurological research.

2021 MSWA Commitment to Research 2021 Announcement.
MSWA-funded researchers providing hope for those living with MND

A study funded by MSWA is examining factors influencing quality of life for people living with motor neurone disease (MND).

Global MND Day - Professor Sulev Koks.
MSWA-supported study focuses on needs of MND family carers

A new national study identified the need for greater emotional support at end of life for family carers of people with motor neurone disease (MND).

Global MND Day - Professor Samar Aoun.
CEO Marcus Stafford Announces Retirement

MSWA CEO will step down from his role in October after 19 years at the helm.

Marcus Stafford MSWA CEO announces retirement.
Nurses: Leading Neurological Support to the Future

Today, on International Nurses Day we celebrate the impact our nurses have on the healthcare system and neurological care.

PBAC Recommends MS Medication Ofatumumab for PBS

Ofatumumab (Kesimpta®) to be subsidised under the Pharmaceutical Benefit Scheme (PBS).